ClearanceBrief
Recall Z-1809-2026 · QFG Alternate Controller Enabled Insulin Infusion Pump

Beta Bionics, Inc.

iLet Ace Pump Kit REF: BB1001 iLet Dosing Decision Software

DateApr 10, 2026 (initiated Aug 13, 2025)
StatusOpen, Classified
Reasonit was found that in versions 1.3.7, 1.4.2, and 1.4.3, the Lock Screen and Limited Access Passcode Screen on the iLet graphical user interface (GUI) include certain icons displayed in the status bar that are active, thereby allowing the user to bypass those screens when those icons on the status bar are pressed, allowing unauthorized access while the device is in Limited Access Mode. A Health Risk associated with Limited access mode includes severe hypoglycemia due to unauthorized access to the iLet if someone were to make unauthorized meal announcements or stopped insulin delivery.
Root causeSoftware design
ActionOn March 12, 2026 Beta Bionics issued a Urgent Medical Device Correction - Expansion/Update via Email to notify new consignees and previous consignees. Initial notification was issued on August 13, 2025. Beta Bionics ask consignees to take the following actions: 1. Download or update your iLet app on your phone. Read the iLet App User Guide. 2. Log into your iLet app. 3. Position your iLet next to your phone with the app open. 4. Go to app settings on the iLet app and follow the on-screen instructions to update to the latest firmware. 5. Complete the acknowledgment survey https://sprw.io/s
Quantity15 units
DistributionUS Nationwide distribution including in the states of AL, AR, AZ, CA, CO, CT, DE, FL, GA, ID, IL, IN, LA, MA, MD, ME, MI, ME, MI, MN, MO, MT, NC, NE, NH, NJ, NV, NY, OH, OK, OR, PA, RI, SC, TN, TX, UT, VA, WA, WI, WY AND WASHINGTON DC.
FDA recordOpen on fda.gov

510(k) clearances named in this recall

K231485iLet® ACE Pump
Beta Bionics, Inc., Jun 21, 2023
K232224iLet® Dosing Decision Software
Beta Bionics, Inc., Sep 22, 2023